GLUCAGON TYPE I PEPTIDE (GLP-1) IMPROVES THE RESPONSE OF BETA GLUCOSE CELLS IN SUBJECTS WITH TOLERANCE DETERIORATED TO GLUCOSE.

摘要

The use of a composition, which comprises a compound that binds to a glucagon-like peptide-1 receptor and a pharmaceutical vehicle for the preparation of a medicament for the treatment of impaired glucose tolerance in a subject not diagnosed with non-insulin dependent diabetes mellitus.